Saint Vincent and the Grenadines vs Turkmenistan: Proportion of the target population who received
Saint Vincent and the Grenadines
99.0%
in 2024
Turkmenistan
99.0%
in 2024
Saint Vincent and the Grenadines rank
1st
Turkmenistan rank
1st
Proportion of the target population who received over time
- Saint Vincent and the Grenadines
- Turkmenistan
How they compare
Saint Vincent and the Grenadines currently reports 99.0% against 99.0% in Turkmenistan, a difference of 0.0%.
The two have swapped places 1 time across 24 shared years of data; in 2001 it was Saint Vincent and the Grenadines ahead.
Saint Vincent and the Grenadines ranks 1st and Turkmenistan ranks 1st of 193 countries.
Turkmenistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saint Vincent and the Grenadines | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.9% | 94.8% | 4.9% | Turkmenistan |
| 2010s | 96.1% | 99.0% | 2.9% | Turkmenistan |
| 2020s | 96.6% | 98.8% | 2.2% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Saint Vincent and the Grenadines or Turkmenistan?
- Saint Vincent and the Grenadines, at 99.0% against 99.0% in Turkmenistan as of 2024.
- What is the difference in proportion of the target population who received between Saint Vincent and the Grenadines and Turkmenistan?
- 0.0%, with Saint Vincent and the Grenadines ahead.
- How many years of comparable data are there for Saint Vincent and the Grenadines and Turkmenistan?
- 24 years are reported by both, from 2001 to 2024.
- How do Saint Vincent and the Grenadines and Turkmenistan rank globally for proportion of the target population who received?
- Saint Vincent and the Grenadines ranks 1st and Turkmenistan ranks 1st of 193 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.